| Adam Isaacson, MD | |
|
2201 Hempstead Tpke, East Meadow, NY 11554-1859 | |
| (516) 572-6525 | |
| (516) 572-3210 |
| Full Name | Adam Isaacson |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 33 Years |
| Location | 2201 Hempstead Tpke, East Meadow, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871561837 | NPI | - | NPPES |
| 01588398 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 194133-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nassau University Medical Center | East meadow, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nassau Health Care Corporation | 2961315221 | 163 |
News Archive
Boston Scientific Corporation today welcomed an announcement by the Interventional Procedures Advisory Committee (IPAC) of the National Institute for Clinical Excellence (NICE), confirming the safety and efficacy of uterine fibroid embolization (UFE), an innovative treatment for fibroids.
Decision Resources Group finds that, when asked to indicate the relative importance of product attributes when prescribing a new drug for Crohn's disease (CD), the highest percentages of surveyed gastroenterologists in the United States and Europe selected efficacy over safety and tolerability or delivery.
Dyax Corp. announced today treatment of the first patient in a Phase 2 trial evaluating the efficacy and safety of ecallantide, a potent, selective, reversible inhibitor of plasma kallikrein, for acute treatment of angiotensin converting enzyme (ACE) inhibitor-induced angioedema.
Regenstrief Institute investigators experienced in the use of data to improve health care and its delivery in resource constrained environments will introduce attendees at MedInfo 2015 to open source options for health information exchange and data analysis.
› Verified 6 days ago
| Entity Name | Nassau Health Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902822992 PECOS PAC ID: 2961315221 Enrollment ID: O20040619000043 |
News Archive
Boston Scientific Corporation today welcomed an announcement by the Interventional Procedures Advisory Committee (IPAC) of the National Institute for Clinical Excellence (NICE), confirming the safety and efficacy of uterine fibroid embolization (UFE), an innovative treatment for fibroids.
Decision Resources Group finds that, when asked to indicate the relative importance of product attributes when prescribing a new drug for Crohn's disease (CD), the highest percentages of surveyed gastroenterologists in the United States and Europe selected efficacy over safety and tolerability or delivery.
Dyax Corp. announced today treatment of the first patient in a Phase 2 trial evaluating the efficacy and safety of ecallantide, a potent, selective, reversible inhibitor of plasma kallikrein, for acute treatment of angiotensin converting enzyme (ACE) inhibitor-induced angioedema.
Regenstrief Institute investigators experienced in the use of data to improve health care and its delivery in resource constrained environments will introduce attendees at MedInfo 2015 to open source options for health information exchange and data analysis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Isaacson, MD 2201 Hempstead Tpke, East Meadow, NY 11554-1859 Ph: (516) 572-6525 | Adam Isaacson, MD 2201 Hempstead Tpke, East Meadow, NY 11554-1859 Ph: (516) 572-6525 |
News Archive
Boston Scientific Corporation today welcomed an announcement by the Interventional Procedures Advisory Committee (IPAC) of the National Institute for Clinical Excellence (NICE), confirming the safety and efficacy of uterine fibroid embolization (UFE), an innovative treatment for fibroids.
Decision Resources Group finds that, when asked to indicate the relative importance of product attributes when prescribing a new drug for Crohn's disease (CD), the highest percentages of surveyed gastroenterologists in the United States and Europe selected efficacy over safety and tolerability or delivery.
Dyax Corp. announced today treatment of the first patient in a Phase 2 trial evaluating the efficacy and safety of ecallantide, a potent, selective, reversible inhibitor of plasma kallikrein, for acute treatment of angiotensin converting enzyme (ACE) inhibitor-induced angioedema.
Regenstrief Institute investigators experienced in the use of data to improve health care and its delivery in resource constrained environments will introduce attendees at MedInfo 2015 to open source options for health information exchange and data analysis.
› Verified 6 days ago
Ajendra S Sohal, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2201 Hempstead Tpke, East Meadow, NY 11554 Phone: 516-572-6525 Fax: 516-572-3170 | |
Thomas Elias Pobre, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2201 Hempstead Tpke, East Meadow, NY 11554 Phone: 516-572-6525 Fax: 516-572-3170 | |
Dr. Thomas Paul Lione, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 801 Merrick Ave, East Meadow, NY 11554 Phone: 516-268-0070 | |
Dr. Ricardo Juan Siochi Cruz Iv, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 200 Carman Ave Apt 1a, East Meadow, NY 11554 Phone: 516-832-7886 Fax: 516-832-7886 | |
Jeffry R. Beer, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 801 Merrick Ave, East Meadow, NY 11554 Phone: 516-393-8941 Fax: 516-393-8870 | |
Jessica West, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2201 Hempstead Tpke, East Meadow, NY 11554 Phone: 805-660-1146 | |
Dr. Miranda Boone Smith, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 801 Merrick Ave, East Meadow, NY 11554 Phone: 516-393-8941 |